• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Imaging and Intervention

Lessons from real-world implementation of lung cancer screening

byJames EnglandandAnees Daud
February 1, 2017
in Imaging and Intervention, Oncology, Public Health
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In this clinical demonstration project of implementing lung cancer screening for smokers in selected Veterans Health Administration hospitals, there were challenges in project implementation and patient selection. There was significant variability in local implementation and radiographic detection of nodules.

2. Increasing the scale of lung cancer screening to the entire VHA is estimated to include around 900,000 patients, which may lead to significant incidental findings. In this population, there was an increased incidence of nodule identification than in prior trials

Evidence Rating Level: 2 (Good)       

Study Rundown: The National Lung Screening Trial (NLST) demonstrated reduction in lung cancer mortality when screening for lung cancer in high-risk individuals with low-dose computed tomography scans. There has been hesitancy with widespread implementation of this program because of resources needed, risk of increased interventions for non-malignant legions, and appropriate patient selection. The current report details the experiences of implementing lung cancer screening (LCS) in 8 VHA hospitals.

At the eight sites, there were significant variations in identifying and enrolling patients. Of note, despite the relatively robust electronic medical records system shared amongst the sites, accurate smoking history was unavailable for a large number of individuals (~40%). Close to two-thirds of eligible patients agreed to go forward with screening, of whom more than half had nodules identified that required tracking with subsequent scans, which was substantially more than in the original NLST. There was variation in the rate of nodule identification based on site of evaluation. A small number (3.5%) underwent diagnostic evaluation and lung cancer was confirmed in 1.5% of patients screened. Incidental conditions such as emphysema, pulmonary abnormalities, and coronary artery calcification were identified in 40% of patients screened. Based on the incidence of patients identified for LCS, implementation across all VHA hospitals is estimated to encompass close to 900,000 patients for screening. Implementation would require substantial clinical and administrative effort to manage the burden of increased number of scans and diagnostic interventions. The study had key limitations including the lack of current data on mortality outcomes, and the predominantly older, male population with high rate of smoking use leading to potentially more common positive findings than the general population.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

American Cancer Society recommends regular PSA-based screening for men at average and higher risk

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Relevant Reading: Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement

In-Depth [prospective cohort]: This study included 8 VHA hospitals chosen based on facilities and staff required to implement a LCS program. Enrolment was in two steps, with initial selection for those aged 55 to 80 years, without prior diagnosis of cancer, with an expected life expectancy of greater than 6 months, and who had known 30-pack-years or greater smoking history. Patients were excluded if they had CT chest within 12 months, or if primary care physicians felt there was significant comorbidity limiting life expectancy to less than 5 years.

Of the 93,033 patients who met initial inclusion, 39.3% had no smoking history available. After all exclusion criteria were applied 4,246 patients were offered screening with 57.7% agreeing to the program. The population that received screening was therefore 2,028 people (96.3% male; 52.5% over the age of 65). A total of 59.7% had a positive screening result, with the majority identifying nodules that would need further tracking. Across the eight sites there was significant variation in nodule detection (from 30.7% to 85.0% of patients screened). A small proportion (3.5%) underwent diagnostic evaluation for lung cancer, and 1.5% of the total screened population had a lung neoplasm. Twenty of the 31 cancers were stage 1.

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancer screeninglung cancersmoking
Previous Post

Young men exposed to violence at risk for carrying guns

Next Post

Late-life mentally stimulating activities may decrease risk of mild cognitive impairment

RelatedReports

Collage on the PSA blood test: an engraved bladder and prostate, a capped blood tube, a balance scale and a blank calendar
2MM Trial Briefs

American Cancer Society recommends regular PSA-based screening for men at average and higher risk

November 12, 2026
A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
Physical activity collage: a smiling middle-aged man in a track jacket beside a city bicycle and a teal resistance band
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Lung cancer screening collage: a smiling white-haired man beside engraved lungs with a magnifying glass over the upper lobe
Oncology

Lung cancer screening models show variable performance across populations

June 29, 2026
Next Post

Late-life mentally stimulating activities may decrease risk of mild cognitive impairment

2 Minute Medicine Rewind January 30, 2017

Crizanlizumab use lowers rates of sickle cell crises

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Removing Race and Ethnicity From Dialysis Mortality Risk Adjustment Changes Facility Performance Rankings
  • AI Model Shows Promise in Predicting PTSD Risk Following Trauma
  • 2 Minute Medicine Rewind November 16, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.